biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	0CDF84E1-52C8-43C3-BBEF-FE1E089370A1
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BC-4073-01B-02R
biospecimen__bio__bcr_portion_barcode	TCGA-BC-4073-01B-02
biospecimen__bio__bcr_sample_barcode	TCGA-BC-4073-01B
biospecimen__bio__biospecimen_barcode_bottom	0108433631
biospecimen__bio__day_of_creation	26
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-BC-4073.1C53BF2E-0AA8-477F-8281-63455E0D36E2.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	A
biospecimen__bio__portion_sequence	2
biospecimen__bio__quantity	3.20
biospecimen__bio__vial_number	B
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2010
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-BC-4073
biospecimen__shared__patient_id	4073
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	CEB40D72-7C2D-47CD-BE8A-D1AEA4E80F3B
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__bilirubin_lower_limit	0.0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.5
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hemochromatosis
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	440
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	73
clinical__clin_shared__bcr_followup_barcode	TCGA-BC-4073-F6829
clinical__clin_shared__bcr_followup_uuid	2CD7C266-0039-4E43-98B0-8364233C1F62
clinical__clin_shared__cancer_first_degree_relative	3
clinical__clin_shared__day_of_form_completion	21
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	253
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__regimen_indication	OTHER, SPECIFY IN NOTES
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R1
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2010
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__rx__bcr_drug_barcode	TCGA-BC-4073-D6868
clinical__rx__bcr_drug_uuid	63E0D664-0D86-4265-8609-3CA1E342E63B
clinical__rx__days_to_drug_therapy_start	166
clinical__rx__drug_name	Sorafenib
clinical__rx__prescribed_dose	200
clinical__rx__prescribed_dose_units	mg
clinical__rx__regimen_number	1
clinical__rx__route_of_administration	PO
clinical__rx__therapy_ongoing	YES
clinical__rx__therapy_type	Chemotherapy
clinical__rx__total_dose	800
clinical__rx__total_dose_units	mg/day
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	f393d38d-5541-4707-a7b9-244f4501e230
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BC-4073-01B-02R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	af804bd9-5c45-46b9-a7fb-19a500c3da94
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	f70a775b-0d52-4424-a318-8c633c3b558b
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	00f209c3-041a-4c6e-8b0f-6383eb3c85fc
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:40:54.554160-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	ec073edd-50f5-5e34-a41b-6fe8a7aa06fe
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1936
gdc__diagnoses__age_at_diagnosis	26795
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-26795.0
gdc__diagnoses__days_to_last_follow_up	849.0
gdc__diagnoses__diagnosis_id	ab52cd53-015f-52a3-a8cc-2d164f0b2be5
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__exposure_id	0ff45015-ede3-5356-b53c-a057aa23f454
gdc__file_id	a505f095-8bc4-4191-92bf-e47e4ece69e0
gdc__file_name	9895d0e5-e30f-434f-9839-ac6f727832fe.mirbase21.mirnas.quantification.txt
gdc__file_size	50331
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	7545812ee4dc7a22232fa2f74e1decbb
gdc__portions__is_ffpe	false
gdc__portions__portion_id	1f07d87c-61db-46b2-8928-2e35a9551caa
gdc__portions__portion_number	02
gdc__portions__weight	56.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	398
gdc__samples__initial_weight	230.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	1C53BF2E-0AA8-477F-8281-63455E0D36E2
gdc__samples__sample_id	9c101575-699b-4629-8a69-e57fe2d0c727
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	20.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	70.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	BOTTOM
gdc__slides__slide_id	32a80a5a-0f35-4faa-8ad7-182cf4c12f28
gdc__submitter_id	mirna_swap_dr11_295_MirnaExpression81ef541f-ff51-4e2d-8cf7-d79a4ca13f30_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BC
gdc__tissue_source_site__name	UNC
gdc__tissue_source_site__tissue_source_site_id	735fda57-1a46-5afd-a1c0-99af9115c0af
gdc__treatments__treatment_id	2ce8d7ed-dcd3-584f-acd3-b26c519e7238
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:12:03.172+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/f393d38d-5541-4707-a7b9-244f4501e230-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/f393d38d-5541-4707-a7b9-244f4501e230-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129702
manually_curated__local_md5	42b8fe1b13f6cdb2bfbb6bafe72bd9e4
manually_curated__opengdc_download_date	2018-10-16T17:10:54.000894+02:00
manually_curated__opengdc_file_md5	6cde722274fa0a6bb676c5ad3f561e18
manually_curated__opengdc_file_size	50330
manually_curated__opengdc_id	f393d38d-5541-4707-a7b9-244f4501e230-meq
manually_curated__origin_file_size	129702
manually_curated__origin_last_modified_date	Tue Oct 16 17:17:00 CEST 2018
manually_curated__origin_md5	42b8fe1b13f6cdb2bfbb6bafe72bd9e4
manually_curated__tissue_status	tumoral
